BIOCHEMICAL FOUNDATIONS OF IRON METABOLISM AND ERYTHROCYTE METABOLISM IN ANEMIAS
Keywords:
anemia, iron metabolism, erythrocyte metabolism, anaerobic glycolysis, two,three-bisphosphoglycerate, adenosine triphosphate, glucose-six-phosphate dehydrogenase, reduced glutathione, hepcidin, clinical biochemistry.Abstract
Anemic syndromes represent a diverse group of hematological and systemic disorders unified by a reduction in circulating functional hemoglobin mass and impaired tissue oxygenation, yet underpinned by distinct molecular disruptions in systemic iron kinetics and intra-erythrocytic bioenergetics. Because mature mammalian erythrocytes lack nuclei, mitochondria, and ribosomes, their structural integrity, deformability, and oxygen-carrying capacity rely exclusively on anaerobic Embden-Meyerhof glycolysis, the Rapoport-Luebering bisphosphoglycerate shunt, and the hexose monophosphate oxidative pathway. However, routine clinical evaluations of anemias focus predominantly on peripheral blood counts and basic ferro-kinetic markers, largely neglecting the profound metabolic coupling between systemic iron homeostasis and intracellular erythrocyte energetics. This comprehensive clinical-biochemical study investigates the molecular interplay between systemic iron metabolism indicators and key parameters of intra-erythrocytic carbohydrate, energy, and redox metabolism across patients diagnosed with iron deficiency anemia and anemia of chronic inflammation. A cohort of patients with clinically confirmed anemic syndromes was systematically evaluated alongside an age- and sex-matched healthy control group. Biochemical profiling encompassed the quantification of serum iron, transferrin saturation, ferritin, soluble transferrin receptors, and hepcidin-twenty-five, coupled with the spectrophotometric and chromatographic assessment of intra-erythrocytic adenosine triphosphate, two,three-bisphosphoglycerate, glucose-six-phosphate dehydrogenase activity, pyruvate kinase activity, reduced glutathione, methemoglobin, and membrane malondialdehyde levels. The findings demonstrate that while iron deficiency anemia and anemia of chronic inflammation exhibit divergent hepcidin and ferritin profiles, both conditions induce a severe depletion of intra-erythrocytic adenosine triphosphate and reduced glutathione, accompanied by a compensatory surge in two,three-bisphosphoglycerate, elevated methemoglobin formation, and accelerated membrane lipid peroxidation. Furthermore, transferrin saturation and blood hemoglobin correlated positively with erythrocyte adenosine triphosphate and glucose-six-phosphate dehydrogenase activity, and inversely with intra-erythrocytic two,three-bisphosphoglycerate and membrane malondialdehyde concentrations. The study concludes that simultaneous evaluation of systemic iron kinetics and intra-erythrocytic metabolic biomarkers provides a comprehensive pathophysiological framework for differentiating anemic syndromes, assessing erythrocyte functional viability, and optimizing combined metabolic and ferro-therapeutic interventions.
References
1.Weiss, G., Ganz, T., & Goodnough, L. T. (2019). Anemia of inflammation. Blood, 133(1), 40-50.
2.Camaschella, C. (2019). Iron deficiency. Blood, 133(1), 30-39.
3.Nemeth, E., & Ganz, T. (2023). Hepcidin and iron in health and disease. Annual Review of Medicine, 74, 261-277.
4.Moras, M., Lefevre, S. D., & Ostuni, M. A. (2017). From erythroblasts to mature red blood cells: organelle clearance in mammals. Frontiers in Physiology, 8, 1076.
5.van Wijk, R., & van Solinge, W. W. (2005). The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood, 106(13), 4034-4042.
6.Mohandas, N., & Gallagher, P. G. (2008). Red cell membrane: past, present, and future. Blood, 112(10), 3939-3948.
7.Mulquiney, P. J., & Kuchel, P. W. (1999). Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations. Biochemical Journal, 342(3), 567-580.
8.MacDonald, R. (1977). Red cell 2,3-diphosphoglycerate and oxygen affinity. Anaesthesia, 32(6), 544-553.
9.Cappellini, M. D., & Fiorelli, G. (2008). Glucose-6-phosphate dehydrogenase deficiency. The Lancet, 371(9606), 64-74.
10.Nagababu, E., Gulyani, S., Earley, C. J., Cutler, R. G., Mattson, M. P., & Rifkind, J. M. (2008). Iron-deficiency anemia enhances red blood cell oxidative stress. Free Radical Research, 42(9), 824-829.
11.Goodnough, L. T., Nemeth, E., & Ganz, T. (2010). Detection, evaluation, and management of iron-restricted erythropoiesis. Blood, 116(23), 4754-4761.
12.Sun, K., Zhang, Y., D'Alessandro, A., Nemkov, T., Song, A., Wu, H., & Xia, Y. (2016). Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia. Nature Communications, 7(1), 12086.
13.Betz, T., Lenz, M., Joanny, J. F., & Sykes, C. (2009). ATP-dependent fluctuations characterize the mechanical properties of the red blood cell membrane. Proceedings of the National Academy of Sciences, 106(36), 15320-15325.
14.Kuhn, V., Diederich, L., Keller, T. C., Kramer, C. M., Lückstädt, W., Panknin, C., & Cortese-Krott, M. M. (2017). Red blood cell function and dysfunction: redox regulation, nitric oxide metabolism, anemia. Antioxidants & Redox Signaling, 26(13), 718-742.
Austria
Uzbekistan
United States
United Kingdom
Germany
France
Italy
Spain
Turkey
Saudi Arabia
United Arab Emirates
Qatar
Egypt
Jordan
India
Pakistan
Bangladesh
China
Japan
South Korea
Malaysia
Indonesia
Kazakhstan
Kyrgyzstan
Tajikistan